- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 18.02.2026 | 1.399 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 18.02.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 18.02.2026ISIN NameDE000A31C3Y4 ALTECH... ► Artikel lesen | |
| 18.02. | XFRA Q3I: AUSSETZUNG/SUSPENSION | 253 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILADDVISE GROUP AB... ► Artikel lesen | |
| 16.02. | ADDvise Group AB (publ): Resolutions at the extraordinary general meeting in ADDvise Group AB (publ) | 472 | GlobeNewswire (Europe) | At the extraordinary general meeting in ADDvise Group AB (publ) ("ADDvise") held today on 16 February 2026, Mia Tomczak and Richard Jernberg were elected as new board members of the company. The resolution... ► Artikel lesen | |
| ADDVISE GROUP Aktie jetzt für 0€ handeln | |||||
| 12.02. | ADDvise Group AB (publ): Year-end report 2025, January 1-December 31 | 355 | GlobeNewswire (Europe) | Increased profits, profitability and stable cash flow. In the fourth quarter, organic sales increased by 4.0% in constant currency and an increase of 1.5% for the full year 2025. Our focus on operational... ► Artikel lesen | |
| 03.02. | ADDvise Group AB (publ): Delisting of the shares and warrants in ADDvise from Nasdaq First North | 300 | GlobeNewswire (Europe) | On 29 January 2026, ADDvise Group AB (publ) ("ADDvise") announced that its board of directors had applied for delisting of the shares and warrants in ADDvise from Nasdaq First North Premier Growth Market... ► Artikel lesen | |
| 29.01. | ADDvise Group AB (publ): ADDvise has applied for delisting of its shares and warrants from Nasdaq First North | 301 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex"), announced a public offer (the "Offer") to the holders of shares and warrants of ADDvise Group AB (publ) ("ADDvise"). On 27 January 2026, Amplex announced that... ► Artikel lesen | |
| 14.01. | ADDvise Group AB (publ): ADDvise announces financial update for 2025 | 281 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex" or the "Bidder") announced a public offer to the holders of shares and warrants in ADDvise Group AB (publ) ("ADDvise" or the "Company") to transfer all their... ► Artikel lesen | |
| 05.01. | ADDvise Group AB (publ): Statement from the independent bid committee of ADDvise in relation to the public offer from Amplex | 283 | GlobeNewswire (Europe) | The independent bid committee of ADDvise recommends that holders of shares and warrants who have a short-term perspective on their ownership or who do not wish to be owners in a listed ADDvise with... ► Artikel lesen | |
| 02.01. | ADDvise Group AB (publ): ADDvise initiates a written procedure under its outstanding bonds 2025/2028 in light of the public offer from Amplex | 518 | GlobeNewswire (Europe) | ADDvise Group AB (publ) (the "Company" or "ADDvise") has instructed the agent under the Company's outstanding bonds 2025/2028 with ISIN SE0025011885 (the "Bonds") to initiate a written procedure in... ► Artikel lesen | |
| 19.12.25 | ADDvise Group AB (publ): Amplex has increased the consideration in the public offer to the shareholders and warrant holders of ADDVise | 267 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex" or the "Bidder") announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) ("ADDvise" or the "Company") to transfer all shares... ► Artikel lesen | |
| 10.12.25 | ADDvise Group AB (publ) receives observation status | 511 | GlobeNewswire | Today, December 10, 2025, Amplex AB disclosed a public offer to the other shareholders and equity rights holders of ADDvise Group AB (publ).
The rules of Nasdaq First North Growth Market state... ► Artikel lesen | |
| 10.12.25 | ADDvise Group AB (publ): ADDvise's board of directors evaluates the public offer from Amplex | 447 | GlobeNewswire (Europe) | Amplex AB ("Amplex") has today announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) ("ADDvise") to transfer all shares and warrants in ADDvise to Amplex at a price... ► Artikel lesen | |
| 12.11.25 | ADDvise Group AB (publ): ADDvise receives order worth USD 2.3 million | 278 | GlobeNewswire (Europe) | ADDvise Group's subsidiary MRC Systems has received an order from IPS. IPS are a global engineering firm that delivers complex projects within life science. The order is worth approximately USD 2.3... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 41,470 | +2,14 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" mit einem Kursziel von 32,30 Euro belassen. Entgegen seinen Erwartungen seien die Konsensschätzungen an die Quartalszahlen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,890 | +0,70 % | Siemens Healthineers steht vor einer wichtigen Bewährungsprobe | Siemens Healthineers nähert sich einem entscheidenden Moment. Nach einer längeren Phase der Unsicherheit hat sich die Aktie zuletzt erholt, doch operativ bleibt der Medizintechnikkonzern ein Unternehmen... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 34,760 | +0,12 % | Weniger Blendung bei 64 Prozent der Testpersonen: Wie ZEISS Licht im Brillenglas steuert | ||
| INTUITIVE SURGICAL | 401,85 | -0,15 % | ISRG Sales Jump 22%: Can Growth Stay Ahead of Procedure Volumes? | ||
| UNITEDHEALTH | 367,80 | -0,27 % | UnitedHealth Group To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Tuesday | ||
| MEDTRONIC | 87,04 | +0,14 % | Medtronic Spark Scholarship Applications Now Open for Students Pursuing Careers in Healthcare Technology | Up to 100 scholarships will be awarded globally to students pursuing degrees or credentials in health tech fields. NORTHAMPTON, MA / ACCESS Newswire / October 28, 2026 / Medtronic, a global leader in... ► Artikel lesen | |
| THERMO FISHER | 637,40 | -0,03 % | Thermo Fisher Scientific (TMO) Benefits on Broad-Based Recovery Across Life-Science Markets | ||
| TELADOC HEALTH | 7,762 | -0,41 % | Stifel hebt Kursziel für Teladoc Health an: Kostensenkungen stärken Margen | ||
| HIMS & HERS HEALTH | 25,780 | -0,46 % | Novo Nordisk, Eli Lilly oder Hims & Hers: Welche Abnehmspritzen-Aktie im Trend-Check vorne liegt - Jetzt lesen! | ||
| BICO GROUP | 2,205 | +0,46 % | Cellink mit EILMELDUNG: Folgt jetzt der nächste Kursrutsch? - Jetzt handeln, noch vor Börsenschluss! | ||
| EUROFINS SCIENTIFIC | 86,84 | +0,16 % | Eurofins Scientific SE: Eurofins Scientific: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be... ► Artikel lesen | |
| BECTON DICKINSON | 175,55 | -1,21 % | BD begins US rollout of next-gen liver stent graft | ||
| ALIGN TECHNOLOGY | 139,00 | +0,83 % | Ihre wichtigsten Termine: Apple, Ebay, Microsoft, Alphabet, Biogen und Boston Scientific legen Zahlen vor! | © Foto: Andrej Sokolow - dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag Enthaltene Werte: US0162551016... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | NuGen Medical Devices Inc.: NuGen Announces Loan Agreement with Sol-Millennium Medical HK Limited | Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce the entering into of a loan agreement (the "Loan Agreement")... ► Artikel lesen | |
| INMODE | 12,335 | +1,86 % | InMode Ltd. - 6-K, Report of foreign issuer |
ADDVISE GROUP AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,142 Euro und damit 0,00 % im Plus. Die Dividendendrendite beträgt aktuell 0,00 % (berechnet anhand der Ausschüttung von 0,00 Euro in den letzten 12 Monaten).
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADDVISE GROUP AB finden Sie auf Wallstreet Online.